Suppr超能文献

玻璃体切除眼中的睫状体平坦部切除术:一种新型青光眼滤过技术的初步报告

Pars Planectomy: Preliminary Report of a New Glaucoma Filtering Technique in Vitrectomized Eyes.

作者信息

Wangsupadilok Boonchai, Tansuebchueasai Natchada

机构信息

Department of Ophthalmology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.

出版信息

Clin Ophthalmol. 2021 Feb 23;15:791-798. doi: 10.2147/OPTH.S299347. eCollection 2021.

Abstract

PURPOSE

To propose a new filtering technique in vitrectomized eyes with glaucoma and report its clinical results and safety.

METHODS

The medical records of 13 eyes that developed glaucoma following pars plana vitrectomy and underwent pars planectomy, from 2011 to 2018, at Songklanagarind hospital, Hatyai, Songkhla, Thailand were retrospectively reviewed. The main outcome measures were visual acuity (VA), intraocular pressure (IOP), number of glaucoma medications, and postoperative complications. Surgical success was defined as IOP value at the last visit of 6-21 mmHg, regardless of anti-glaucoma medication usage, and without further glaucoma surgery.

RESULTS

The mean follow-up duration was 47.7 ± 32.1 months (range, 0.3-101.1 months). Preoperative BCVA increased from LogMAR 1.01 ± 0.85 to 1.2 ± 0.91 at the last visit (p = 0.233). The mean preoperative IOP was 28.15 ± 9.17 mmHg with an average of 3.46 ± 0.52 anti-glaucoma medications. At the final visit, the mean IOP was 14.08 ± 4.89 mmHg (p = 0.006) and the mean number of anti-glaucoma medications decreased to 1.31 ± 1.38 (p = 0.000). The probability of surgical success was 58.3%, 50%, and 37.5% at 1, 2, and 6 years after pars planectomy, respectively. Postoperative complications included vitreous hemorrhage in 1 eye (7.7%). No retina and pars plicata associated complications were found.

CONCLUSION

Pars planectomy is efficient and safe as well as requires a short learning curve. It should be considered as an alternative filtering surgery in glaucoma after vitrectomy, especially with an extensive limbal scar that might be a limitation in trabeculectomy and GDDs techniques and outcomes.

摘要

目的

提出一种针对青光眼玻璃体切除术后眼睛的新型滤过技术,并报告其临床结果及安全性。

方法

回顾性分析2011年至2018年在泰国宋卡府合艾市宋卡兰纳格林医院接受过玻璃体切除术后发生青光眼并接受了睫状体扁平部切除术的13只眼睛的病历。主要观察指标为视力(VA)、眼压(IOP)、青光眼药物使用数量及术后并发症。手术成功定义为末次随访时眼压值在6 - 21 mmHg,无论是否使用抗青光眼药物,且无需进一步进行青光眼手术。

结果

平均随访时间为47.7 ± 32.1个月(范围0.3 - 101.1个月)。末次随访时,术前最佳矫正视力(BCVA)从LogMAR 1.01 ± 0.85提高到1.2 ± 0.91(p = 0.233)。术前平均眼压为28.15 ± 9.17 mmHg,平均使用3.46 ± 0.52种抗青光眼药物。末次随访时,平均眼压为14.08 ± 4.89 mmHg(p = 0.006),抗青光眼药物平均使用数量降至1.31 ± 1.38种(p = 0.000)。睫状体扁平部切除术后1年、2年和6年手术成功的概率分别为58.3%、50%和37.5%。术后并发症包括1只眼发生玻璃体积血(7.7%)。未发现视网膜及睫状体扁平部相关并发症。

结论

睫状体扁平部切除术高效、安全,且学习曲线短。对于玻璃体切除术后青光眼,尤其是存在广泛角膜缘瘢痕可能限制小梁切除术和青光眼引流装置技术及效果的情况,应考虑将其作为一种替代性滤过手术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7175/7914065/400ae2e7a9e8/OPTH-15-791-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验